Intrahepatic enrichment of IL-22 in chronic hepatitis B (CHB) or C (CHC) patients, while not directly impacting the replication of HBV and HCV in hepatocytes (120, 214, 220, 222, 223), suggests a crucial role of the cytokine in the progression of liver disease. This evidence concerns the gene IL22 and liver disorder.